Dr hab. Katarzyna Batani from the Institute of Plasma Physics and Laser Microfusion (IPPLM) has become a member of the Management Committee of COST Action CA23151 – Mediterranean Cancer Screening and Early Diagnosis Network (Medi-CaSE).
The project was established to help reduce disparities in the implementation of cancer control policies and screening programmes between high-, middle- and low-income countries. It also aims to support cooperation and promote innovation in cancer prevention.
Participation in this programme will support research conducted at IPPLM on the development of new methods for producing radioisotopes relevant to cancer diagnostics (43Sc, 44Sc). This work is based on the use of low-energy, short-pulse lasers with a high repetition rate.
More information about the project is available at:
nsp_133.JPG)
nsp_133.JPG)
